Abstract
On completion of chemical synthesis of the peptide chain, the final step requires the removal from the solid-phase support and liberation of the protected side chains of the trifunctional amino acids (1). Many different approaches to this problem have been established, but the procedure most widely used for all Boc/Bzl-based peptides has been treatment with liquid HF.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Merrifield, R. B. (1963) Solid phase synthesis peptide synthesis: the synthesis of a tetrapeptide. J. Am. Chetn. Soc. 85, 2149–2154.
Hyman, H H and Garber, R. A. (1959) The Hammet acidity function Ho for trifluoroacetic acid solutions of sulfuric and hydrofluoric acids J Am Chem Soc. 81, 1847–1849.
Sakakibara, S(1971) The use of hydrogen fluoride in peptide chemistry, in Chemistry and Biochemistry of Amino Acids, Peptides and Proteins, vol. 1 (Weinstein, B, ed), Dekker, New York, pp. 51–85.
Erickson, B W. and Merrifield, R. B. (1973) The acid stability of several benzylic protecting groups used in solid-phase peptide synthesis. The rearrangement of O-benzyltyrosme to 3-benzyltyrosine. J. Am. Chem Soc. 95, 3750–3756
Engelhard, M and Merrifield, R. B (1978) Tyrosine protecting groups: minimization of rearrangement to 3-alkyltyrosine during acidolysis. J. Am. Chem. Soc. 100, 3559–3563.
Yamashiro, D. and Li, C. H. (1973) Protection of tyrosine in solid-phase peptide synthesis. J. Org. Chem. 38, 591,592.
Bodanszky, M. and Martinez, J. (1981) Side reactions in peptide synthesis. Synthesis 333–356.
Lundt, B. F, Johansen, N. C, Voelund, A, and Markussen, J. (1978) Removal of t-butyl and t-butyloxycarbonyl protecting groups with trifluoroacetic acid. Int. J. Peptide and Protein Res. 12, 258–268.
Masui, Y., Chino, N., and Sakakibara, S. (1980) The modification of tryptophan residues during the acidolytic cleavage of Boc-groups. Bull. Chem. Soc. Jpn. 53, 464–468.
Tarn, J. P., Heath, W. F., and Merrifield, R. B. (1982) SN1 and SN2 mechanism for the deprotection of synthetic peptides by hydrogen fluoride. Studies to minimize tyrosine alkylation side reaction. Int. J. Peptide Protein Res. 21, 57–65.
Feinberg, R. S. and Merrifield, R. B. (1975) Modification of peptides containing glutamic acid by hydrogen fluoride-anisole mixtures. Gamma-acylation of anisole or the glutamyl nitrogen. J. Am. Chem. Soc. 97, 3485–3496.
Baba, T., Sugiyama, H, and Seto, S. (1973) Rearrangement of a and (3-aspartyl peptide with anhydrous HF. Chem. Pharm. Bull (Tokyo) 21, 207–209.
Yang, L L. and Merrifield, R. B(1976) The a-phenacyl ester as a temporary protecting group to minimize cyclic imine formation during subsequent treatment of asparty peptides with HF. J. Org. Chem 41, 1032–1041.
Tarn, J. P., Heath, W. F, and Merrifield, R. B. (1983) SN2 deprotection of synthetic peptides with a low concentration of HF in dimethylsulfide evidence and application in peptide synthesis. J. Am. Chem. Soc. 103, 6442,6455.
Tarn, J. P., Heath, W. F., and Merrifield, R. B. (1986) Mechanism for the removal of benzyl protecting groups in synthetic peptides by trifluoromethanesulfonic acid-trifluoroacetic acid-dimethylsulfide. J. Am Chem. Soc. 108, 5242–5251.
Tarn, J. P. and Merrifield, R. B. (1987) Strong acid cleavage of synthetic peptides: mechanisms and methods, in The Peptides: Analysis, Synthesis and Biology, vol. 9 (Meienhofer, J. and Udenfriend SO, eds.), Academic, Orlando, FL, pp. 185–248.
Yajima, H., Fujii, N., Ogawa, H, and Kawatani, H. (1974) Trifluoromethanesulfonic acid, as a deprotection reagent in peptide chemistry. J. Chem. Soc. Chem. Commun. pp. 107,108.
Matsueda, G. R. (1982) Deprotection of Nin-formyl tryptophan residues using 1,2 ethanedithiol in liquid hydrogen fluoride. Int. J. Peptide Protein Res. 20, 26–34.
Stewart, J. M. and Young, J. D. (1984) in Solid Phase Peptide Synthesis, Pierce Chemical Co., Rockford IL.
Tarn, J. P., Wong, T. W., Riemen, M. W., Tjoeng, F. S., and Merrifield, R. B. (1979) Cyclohexyl ester as a new protecting group for aspartyl peptides to minimize aspartimide formation in acidic and basic treatments. Tet. Lett. 42, 4033–4036.
Heath, W. F, Tarn, J P., and Merrifield, R. B. (1986) Improved deprotection of cysteine-containing peptides in HF. Int. J. Peptide Protein Res. 28, 498–507.
Garsky, V. M., Lumma, P. K, Freidinger, R. M., Pitzenberger, S. M., Randall, W. C, Veber, D. F., Gould, R. J., and Friedman, P. A. (1989) Chemical synthesis of echistatin, a potentent inhibitor of platelet aggregation from Echi carinatus: synthesis and biological activity of selected analogs. Proc. Natl. Acad. Set USA 86, 4022–4026.
Westerberg, P, Wernstedt, C, Wilander, E., Hayden, D W., O’Brien, T. D., and Johnson, K. H. (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. USA 84, 3881–3885
Hope, D B., Murti, V. V S, and Du Vigneaud, V. (1962) A highly potent analog of oxytocin, desaminooxytocin. J. Biol. Chem. 237, 1563–1566.
Sawyer, T J., Staples, D. J, de Launo Castucci, A M, and Hadley, M. E. (1989) Discovery and structure-activity relationships of novel α-melanocyte stimulating hormone inhibitors Peptide Res. 2, 140–146
Chandler, P., Pennington, M. W., Maccecchini, M. L., Nashed, N, and Skolnick, P (1993) Polyamme-like actions of peptides derived from conantokin-G, an NMDA antagonist J.Biol Chem 268, 17,173–17,178
Tanaka, M, Haniu, M., Yasunobu, K. T., and Norton, T R. (1977) Amino acid sequence of the Anthopleura xanthogrammica heart stimulant anthopleurin-A. Biochemistry 16, 204–208.
Tarn, J. P. (1987) Synthesis of biologically active transforming growth factor alpha. Int. J. Peptide Protein Res 29, 421–431.
Pennington, M. W, Festin, S. M., Maccecchini, M. L, Dick, F., and Scarborough, P. E. (1991) HIV protease, chromogenic substrate and inhibitor, in Peptides 1990 (Giralt, E and Andreu, D. eds.), Escom, Leiden, Netherlands, pp. 787–789
Bangalore, N., Travis, J., Onuka, V C, Pohl, J., and Shafer, W M. (1990) Identification of the primary antimicrobial domains in human neutrophil cathepsin-GJ. Biol. Chem. 265, 13,584–13,588.
Gan Z R, Gould, R. J., Jacobs, J W, Friedman, P. A.,and Polokoff, M. A.(1988) Echistatin, a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J. Biol Chem. 263, 19,827–19,832.
Bartfai, T., Bedecs, K., Land, T., Langel, U., Bertorelli, R., Girotti, P., Console S., Xu, X, Hallin, Z., Nilsson, S., Pieribone, V., and Hokfelt, T. (1991) M-15: high affinity chimenc peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus and spinal cord. Proc. Natl. Acad Sci. USA 88, 10,961–10,965.
Veber, D. F., Milkowski, J. D., Varga, S., Denkewalter, R. G., and Hirshmann, R (1972) Acetamidomethyl: a novel thiol protecting group for cysteine. J. Am Chem. Soc. 94, 5456–5461.
Kamber, B. (1971) Cystin peptide aus (S-acetamidomethyl-cystein)-peptiden durch oxydation mit jod· die synthese con cyclo-cystin. Helv Chim. Acta 54, 927–930
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Humana Press Inc.
About this protocol
Cite this protocol
Pennington, M.W. (1994). HF Cleavage and Deprotection Procedures for Peptides Synthesized Using a Boc/Bzl Strategy. In: Pennington, M.W., Dunn, B.M. (eds) Peptide Synthesis Protocols. Methods in Molecular Biology, vol 35. Humana Press, Totowa, NJ. https://doi.org/10.1385/0-89603-273-6:41
Download citation
DOI: https://doi.org/10.1385/0-89603-273-6:41
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-273-6
Online ISBN: 978-1-59259-522-8
eBook Packages: Springer Protocols